USD 1.07
Price
-0.00
(-0.14%)
Day Change
|
|
---|
ACHL, the overall quality is not good (Quality = 38) but the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...
Quality Factors |
|
45% |
Timing Factors |
|
85% |
Financial Health |
|
50% |
Ability to Make Profit |
|
37% |
Return to Investors |
|
4% |
Registration Details |
Analyze Date | 2024-11-27 20:28:11 |
Symbol | ACHL |
Name | ACHILLES THERAPEUTICS PLC ADR |
Sector | Healthcare >> Biotechnology |
Market | NASDAQ |
Listed Shares | 41.09 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 45.71 / 3,618.74 |
News, Concensus, ... |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |